Expression of interleukin-6 is greater in preadipocytes than in adipocytes of 3T3-L1 cells and C57BL/6J and ob/ob mice

被引:131
作者
Harkins, JM
Moustaid-Moussa, N
Chung, YJ
Penner, KM
Pestka, JJ
North, CM
Claycombe, KJ [1 ]
机构
[1] Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA
[2] Univ Tennessee, Dept Nutr, Knoxville, TN 37996 USA
关键词
interleukin-6; preadipocyte; obesity;
D O I
10.1093/jn/134.10.2673
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Inflammation plays a major role in the development of chronic diseases such as cardiovascular disease and Type 2 diabetes. Further, it was demonstrated that obese animals and humans have significantly higher levels of circulating proinflammatory cytokines, such as interleukin-6 (IL-6). The aim of this study was to determine whether adipose tissue could be a major source of circulating IL-6 in leptin-deficient obese (oblob) mice by comparing the expression of IL-6 in different tissues of oblob mice. Our secondary goal was to determine whether preadipocytes are the source of adipose tissue IL-6. The oblob mice had higher levels of plasma IL-6 (P < 0.05) and adipose tissue IL-6 mRNA (P < 0.05) compared with lean mice. Interestingly, IL-6 mRNA levels of liver and spleen were not different between oblob and lean mice, whereas adipose tissue IL-6 mRNA levels were higher in the oblob mice compared with lean mice (P < 0.05). In addition, we showed that IL-6 secretion from the adipose tissue stromal vascular fraction cells was higher than that from fully differentiated adipocytes (P < 0.001). We further demonstrated that 3T3-L1 preadipocytes had significantly higher levels of lipopolysaccharide (LPS)stimulated IL-6 mRNA and IL-6 secretion than differentiated 3T3-L1 adipocytes. Taken together, these data suggest that adipose tissue and preadipocytes from the adipose tissue stromal vascular fraction may contribute significantly to the increased plasma IL-6 levels in oblob mice.
引用
收藏
页码:2673 / 2677
页数:5
相关论文
共 32 条
[1]   CELLULAR AND MOLECULAR ASPECTS OF ADIPOSE-TISSUE DEVELOPMENT [J].
AILHAUD, G ;
GRIMALDI, P ;
NEGREL, R .
ANNUAL REVIEW OF NUTRITION, 1992, 12 :207-233
[2]   Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss [J].
Bastard, JP ;
Jardel, C ;
Bruckert, E ;
Blondy, P ;
Capeau, J ;
Laville, M ;
Vidal, H ;
Hainque, B .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (09) :3338-3342
[3]   Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-α.: Effect of weight loss in obese men [J].
Bruun, JM ;
Verdich, C ;
Toubro, S ;
Astrup, A ;
Richelsen, B .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2003, 148 (05) :535-542
[4]   Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation [J].
Chavey, C ;
Mari, B ;
Monthouel, MN ;
Bonnafous, S ;
Anglard, P ;
Van Obberghen, E ;
Tartare-Deckert, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (14) :11888-11896
[5]   Ceramide mediates age-associated increase in macrophage cyclooxygenase-2 expression [J].
Claycombe, KJ ;
Wu, DY ;
Nikolova-Karakashian, M ;
Palmer, H ;
Beharka, A ;
Paulson, KE ;
Meydani, SN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (34) :30784-30791
[6]   Regulation of leptin by agouti [J].
Claycombe, KJ ;
Xue, BZ ;
Mynatt, RL ;
Zemel, MB ;
Moustaid-Moussa, N .
PHYSIOLOGICAL GENOMICS, 2000, 2 (03) :101-105
[7]  
Cousin S, 2001, J CELL PHYSIOL, V186, P380, DOI 10.1002/1097-4652(2001)9999:9999<000::AID-JCP1038>3.0.CO
[8]  
2-T
[9]   Weight loss reduces interleukin-18 levels in obese women [J].
Esposito, K ;
Pontillo, A ;
Ciotola, M ;
Di Palo, C ;
Grella, E ;
Nicoletti, G ;
Giugliano, D .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (08) :3864-3866
[10]   Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women - A randomized trial [J].
Esposito, K ;
Pontillo, A ;
Di Palo, C ;
Giugliano, G ;
Masella, M ;
Marfella, R ;
Giugliano, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (14) :1799-1804